| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $173.9M | — | +21.2% |
| Cost of Revenue | $72.8M | — | +31.6% |
| Gross Profit | $101.2M | — | +14.7% |
| R&D Expense | $24.9M | — | +45.0% |
| SG&A Expense | $63.0M | — | +44.4% |
| Operating Income | $13.3M | — | -51.5% |
| Pre-tax Income | $8.5M | — | -68.2% |
| Income Tax | $1.2M | — | +17.7% |
| Net Income | $7.3M | — | -71.5% |
| EPS (Basic) | $0.21 | — | -72.4% |
| EPS (Diluted) | $0.20 | — | -71.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $90.7M | +7.6% | -36.1% |
| Inventory | $49.9M | +2.1% | +15.0% |
| Current Assets | $619.3M | -2.9% | +22.4% |
| Total Assets | $1.43B | +34.3% | +71.3% |
| Current Liabilities | $91.9M | +2.9% | +65.3% |
| Total Liabilities | $940.8M | +58.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $24.5M | — | +959.3% |
| Capital Expenditures | $36.7M | — | +35.6% |
| Investing Cash Flow | -$36.7M | — | -35.6% |
| Financing Cash Flow | $3.8M | — | +24.2% |
| Free Cash Flow | -$12.1M | — | +59.4% |
| +64.7% |
| Stockholders' Equity | $494.0M | +4.4% | +85.5% |